Jinghua Pharmaceutical Group Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Essence Pharmaceutical Group Co., Ltd. is a local state-owned holding enterprise controlled by Nantong Industry Control Group and supervised by state-owned assets. The former Nantong Zhongcheng Pharmaceutical Co., Ltd. (Nantong Traditional Chinese Medicine Factory) has changed and restructured the high-quality resources of Nantong General Pharmaceutical Factory (Nantong Pharmaceutical Factory, Nantong No.2 Pharmaceutical Factory), and was established by absorbing private capital Nantong Variety Investment Co., Ltd. and natural persons. In February 2010, it was listed on the small and medium-sized board of Shenzhen Stock Exchange. The stock abbreviation is essence Pharmaceutical, and the security code is 002349. The company has a pharmaceutical history of over 60 years and is a comprehensive modern GMP pharmaceutical limited company. At present, it has 7 subsidiaries and is a comprehensive pharmaceutical enterprise group that integrates the production, sales, and research and development of traditional Chinese medicine preparations, traditional Chinese medicine decoction pieces, Western medicine preparations, pharmaceutical intermediates, chemical raw materials, biopharmaceuticals, health products, etc. The company has over 200 varieties of traditional Chinese and Western medicine, including the renowned classic Chinese medicine "Five Golden Flowers" Wang's Baochi Pill, Ji Desheng Snake Tablets, Zheng Chaihu Yin Granules, Da Chaihu Granules, Jin Buckwheat Capsules, as well as Gu Ben Ke Chuan Tablets, Yun Ke Ping Syrup, Jing Xue Bu Tablets, etc. These traditional Chinese medicine products have a wide historical background and profound cultural heritage, among which Ji Desheng Snake Tablets The production techniques of Wang's Baochi Pills have been included in the national intangible cultural heritage. The main raw material drug products include phenobarbital, promidone, fluorouracil, paclitaxel, flucytosine, piroxicam, tenoxicam, propylthiouracil, phenacetin, dipyridamole, and other pharmaceutical intermediates. Among them, 10 varieties have passed national GMP certification, 5 varieties have passed EU CEP certification, 2 varieties have passed Australian GMP certification, 3 varieties have passed Mexican official certification, 4 varieties have obtained US DMF registration documents, 1 variety has obtained US VMF registration documents, and has passed on-site FDA inspections in the United States. The company has been ranked among the top 100 Chinese herbal medicine enterprises for many consecutive years, and has been certified as a national high-tech enterprise, provincial technology center, and engineering technology research center. Essence Pharmaceutical will take "becoming a national modern pharmaceutical enterprise with the core characteristics of handed down traditional Chinese medicine" as its strategic goal, thoroughly implement the spirit of the Opinions on Promoting the Inheritance, Innovation and Development of Traditional Chinese Medicine, focus on the "two wheel drive" development strategy of "five golden flowers", the main business of handed down traditional Chinese medicine, supplemented by characteristic chemical raw materials and chemical agents, and rely on brand strength and channel strength, Committed to becoming a national modern pharmaceutical enterprise with traditional Chinese medicine as its core feature. |
| Headquarter | Nantong |
| Establish Date | 1/3/1994 |
| Listed Code | 002349.SZ |
| Listed Date | 2/3/2010 |
| Chairman | Yin Hongyu. |
| CEO | Zhou Yunzhong. |
| Website | www.ntjhzy.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
